Attending #AANAM ? Exhibits are open. Visit us at booth 1635 to learn more about JAMA Neurology and the JAMA Network journals and submitting your manuscripts, and to get recent #neurology articles

Meet JAMA Neurology Editor Andy Josephson today at #AANAM at booth 1635 in the exhibit hall. Sunday, April 14, 11:30 AM - 12:00 PM. Stop by to ask questions and talk with him about your research and publishing opportunities in the JAMA Network journals

Attending #AANAM ? Meet the Editor of JAMA Neurology, Andy Josephson, MD at booth 1635 in the exhibit hall:
Sunday, April 14: 11:30 AM - 12:00 PM MT
Tuesday, April 16: 1:00-1:30 PM MT

Most viewed in the last 7 days from JAMA Neurology:

Is seizure prophylaxis associated with reduced risk for early posttraumatic seizures, defined as seizures within 7 days of injury, for patients with mild or moderate TBI?

ja.ma/3Q1HQhk

Batoclimab, an anti-FcRn monoclonal antibody, resulted in a higher rate of sustained Myasthenia Gravis Activities of Daily Living improvement in adult patients with generalized myasthenia gravis compared with placebo. ja.ma/3Uebdzk

Both directly presenting and transferred patients with large ischemic stroke in the SELECT2 trial benefited from endovascular thrombectomy, including those with low ASPECTS at referring hospitals. #ISC24 ja.ma/3J6POBU

Sublingual edaravone dexborneol, as a fasting and convenient agent, could improve the proportion of patients achieving good clinical outcomes at 90 days compared with placebo among patients with acute ischemic stroke. ja.ma/3J6POlo

AI-based LLMs (GPT-4, Bard, and Claude 2) were given 8 practice tests for the ABPN Epilepsy Board Exam, 100 questions each. LLMs were able to achieve passing level scores; some hallucinated logic was noticed. ja.ma/4as6gbM

Most viewed in the last 7 days from JAMA Neurology:

This narrative review focuses on symptoms, occurrence, and appropriate management of neuropsychiatric syndromes in neurogenerative disorders.

ja.ma/4ant9Nz

In this meta-analysis, seizure prophylaxis was effective for mild and moderate TBI to reduce rates of early seizures. ja.ma/3VM1zFr

Viewpoint from Darae Ko, MD, MSc, FAHA et al discusses lecanemab use and the risk of cerebral macrohemorrhage for patients with mild cognitive impairment or early dementia. ja.ma/4aFnSk6

Secondary analysis of a randomized clinical trial examines changes in the progression of progressive supranuclear palsy (PSP) associated with 31 concomitant medication classes used by study participants over 1 year. ja.ma/4a2krEx

In this exploratory neuroimaging study, there was no significant MRI-detectable evidence of brain injury among the group of participants who experienced anomalous health incidents (AHIs) compared with a group of matched controls. ja.ma/3VHAzqk

In a study with 86 participants reporting anomalous health incidents and 30 matched control participants, there were no significant differences in most tests of auditory, vestibular, cognitive, visual function, or blood biomarkers between the groups. ja.ma/3VHWCgT

Case report describes a 56-year-old man with periorbital swelling and hyperpigmentation on the right side of the face and a hypopigmented patch on the anterior chest. ja.ma/3VZzM4z

Most viewed in the last 7 days from JAMA Neurology:

This narrative review focuses on symptoms, occurrence, and appropriate management of neuropsychiatric syndromes in neurogenerative disorders.

ja.ma/4cHjtPD

Study highlights two cases of genetic Creutzfeldt-Jakob disease with atypical diffusion-weighted imaging changes. ja.ma/49P7Ynm

Narrative review discusses several types of gene editing using clustered regularly interspaced short palindromic repeats (CRISPR). ja.ma/3wZobYo

Case report: a 54-year-old woman with naming deficits, comprehension impairment, and memory loss. Initial physical and neurological examination results were unremarkable. ja.ma/3xd8SLU

Progress is being made in new treatments for neuropsychiatric syndromes in neurodegenerative disorders (NDDs). Psychosis, agitation, depression, apathy, and disinhibition occur in NDDs. Neurobiology and drug development are converging to provide Tx. ja.ma/3VHiuZv